JP2023552490A5 - - Google Patents
Info
- Publication number
- JP2023552490A5 JP2023552490A5 JP2023548533A JP2023548533A JP2023552490A5 JP 2023552490 A5 JP2023552490 A5 JP 2023552490A5 JP 2023548533 A JP2023548533 A JP 2023548533A JP 2023548533 A JP2023548533 A JP 2023548533A JP 2023552490 A5 JP2023552490 A5 JP 2023552490A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring
- optionally substituted
- cycloalkyl
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092893P | 2020-10-16 | 2020-10-16 | |
| US63/092,893 | 2020-10-16 | ||
| PCT/US2021/055165 WO2022093552A2 (en) | 2020-10-16 | 2021-10-15 | Rev-erb agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552490A JP2023552490A (ja) | 2023-12-15 |
| JP2023552490A5 true JP2023552490A5 (cg-RX-API-DMAC7.html) | 2024-10-21 |
Family
ID=81384462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548533A Pending JP2023552490A (ja) | 2020-10-16 | 2021-10-15 | Ｒｅｖ－ｅｒｂアゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240002380A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4228632A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023552490A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116635029A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021372389A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195127A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022093552A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432302B (zh) * | 2020-11-05 | 2024-08-27 | 中国科学院上海营养与健康研究所 | 小分子sr9009在抗衰老以及减轻衰老引起的慢性炎症中的用途 |
| CN114907333B (zh) * | 2022-05-11 | 2023-07-04 | 中国人民解放军军事科学院军事医学研究院 | 环丙甲酰胺衍生物及其制备方法和用途 |
| WO2025024550A1 (en) * | 2023-07-25 | 2025-01-30 | University Of Florida Research Foundation, Incorporated | Rev-erb antagonists |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4472193A (en) * | 1982-07-06 | 1984-09-18 | The Dow Chemical Company | Naphthyridinyloxy(or thio)phenoxy propanoic acids, derivatives thereof and methods of herbicidal use |
| ES2200617B1 (es) * | 2001-01-19 | 2005-05-01 | Almirall Prodesfarma, S.A. | Derivados de urea como antagonistas de integrinas alfa 4. |
| WO2008057209A1 (en) * | 2006-10-27 | 2008-05-15 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
| US8258301B2 (en) * | 2007-05-15 | 2012-09-04 | Boehringer Ingelheim International Gmbh | Urotensin II receptor antagonists |
| UY31984A (es) * | 2008-07-16 | 2010-02-26 | Boehringer Ingelheim Int | DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas. |
| TW201026667A (en) * | 2008-09-30 | 2010-07-16 | Merz Pharma Gmbh & Co Kgaa | Glycine b antagonists |
| US9593108B2 (en) * | 2009-04-06 | 2017-03-14 | Ptc Therapeutics, Inc. | Compounds and methods for antiviral treatment |
| AU2011253058A1 (en) * | 2010-05-13 | 2012-12-06 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors |
| WO2013033310A1 (en) * | 2011-08-31 | 2013-03-07 | Theodore Mark Kamenecka | Modulators of rev-erb |
| WO2013045519A1 (en) * | 2011-09-27 | 2013-04-04 | Genfit | Derivatives of 6-substituted triazolopyridazines as rev-erb agonists |
| AU2013216354B2 (en) * | 2012-02-02 | 2017-08-31 | Idorsia Pharmaceuticals Ltd | 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives |
| TW201348231A (zh) * | 2012-02-29 | 2013-12-01 | Amgen Inc | 雜雙環化合物 |
| JP6374384B2 (ja) * | 2012-08-07 | 2018-08-15 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | プロテインキナーゼ阻害剤としてのピリドピリミジン誘導体 |
| CA2894126A1 (en) * | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| WO2015103527A1 (en) * | 2014-01-06 | 2015-07-09 | The Scripps Research Institute | Modulators of rev-erb |
| SG11201705192PA (en) * | 2014-12-24 | 2017-07-28 | Gilead Sciences Inc | Fused pyrimidine compounds for the treatment of hiv |
| WO2017222951A1 (en) * | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| CN109776335B (zh) * | 2017-11-15 | 2022-03-18 | 武汉尚赛光电科技有限公司 | 芘的胺类衍生物及其制备方法、应用和器件 |
| GB201810486D0 (en) * | 2018-06-26 | 2018-08-08 | Imperial Innovations Ltd | Natural killer cells |
-
2021
- 2021-10-15 AU AU2021372389A patent/AU2021372389A1/en not_active Abandoned
- 2021-10-15 WO PCT/US2021/055165 patent/WO2022093552A2/en not_active Ceased
- 2021-10-15 JP JP2023548533A patent/JP2023552490A/ja active Pending
- 2021-10-15 EP EP21887190.3A patent/EP4228632A4/en not_active Withdrawn
- 2021-10-15 CA CA3195127A patent/CA3195127A1/en active Pending
- 2021-10-15 CN CN202180076854.6A patent/CN116635029A/zh active Pending
-
2023
- 2023-04-13 US US18/134,055 patent/US20240002380A1/en active Pending